PHARMExcel provides specialist Dermatology CRO Services for sponsors conducting clinical trials in skin, hair and related conditions across Phase I-IV research. We work with biotechs, medtech companies, charities and NHS or academic sponsors to help deliver dermatology studies that are scientifically robust, operationally realistic and aligned with the needs of patients, investigators and specialist sites.
Our services are focused on the clinical trial stage, helping sponsors navigate the practical and regulatory challenges of dermatology research through tailored governance, oversight and hands-on clinical operations. This includes studies in medical dermatology, oncology-related dermatology and other specialist dermatological indications where careful protocol planning, endpoint selection and site feasibility are essential.
Dermatology clinical trials explained
Dermatology clinical trials are used to evaluate treatments for a wide range of skin and hair conditions, from common inflammatory diseases through to rare or specialist indications. These studies often rely on a combination of clinical assessment, imaging, photography, patient-reported outcomes and quality of life measures, all of which need to be collected consistently and interpreted carefully across sites.
Because many dermatology conditions are visible, chronic and closely linked to physical comfort, confidence and day-to-day functioning, study design must balance scientific rigour with patient acceptability. Visit schedules, symptom tracking and assessment burden all need to be realistic if sponsors are to generate high-quality data in a way that fits real clinical practice.
Specialised dermatology therapeutic expertise
Dermatology covers a broad and varied clinical landscape, and different indications bring very different trial challenges. PHARMExcel can support studies in inflammatory skin disease, including acne, eczema, psoriasis, hidradenitis suppurativa and vitiligo, as well as hair disorders such as alopecia and dermatology studies linked to oncology pathways.
Our role is to help sponsors shape and deliver protocols that reflect the realities of dermatology care, including endpoint selection, site capability and the lived experience of the patient population. Whether a study is symptom-driven, image-based or dependent on long-term follow-up, we help ensure that the trial design is feasible, well governed and aligned with the clinical setting in which it will be delivered.
Clinical operations, site oversight and study management
PHARMExcel provides governance and oversight across dermatology trial delivery, including study start-up, site selection, monitoring, project management and close out. We work with sponsors to identify the most appropriate dermatology clinics, hospital departments and specialist investigators for each protocol, based on patient population, assessment requirements and study complexity.
Our teams focus on ensuring that trial processes are practical and clearly understood by sites, particularly where studies involve repeated photography, lesion scoring, symptom reporting or other specialist dermatology assessments. We do not directly recruit patients, but we help sponsors establish realistic, site-led recruitment pathways and maintain operational control throughout the study lifecycle.
Regulatory support and dermatology data oversight
PHARMExcel supports dermatology studies with the regulatory and governance input needed to keep trials compliant, well documented and operationally sound. This includes support with ethics committee and regulatory submissions, safety reporting, monitoring oversight, medical writing and data management processes that reflect the needs of the protocol and the patient population.
Dermatology studies often depend on consistent endpoint capture across multiple visits and investigators, particularly where visual assessments or patient-reported outcomes are central to the study. Our role is to help sponsors maintain data quality, protocol fidelity and audit readiness through clear oversight and proportionate clinical trial management.
Patient-centred dermatology trial delivery
Patient experience is especially important in dermatology research because symptoms are often visible, chronic and closely tied to quality of life. Conditions such as eczema, psoriasis, acne, alopecia and vitiligo can carry a significant physical and emotional burden, which means protocols need to be designed and delivered with sensitivity as well as scientific precision.
As a leading UK based Clinical Research Organisation (CRO), PHARMExcel works with sponsors and sites to ensure that dermatology trial processes are realistic for participants, with careful attention to visit burden, communication and the acceptability of assessments. This helps support retention, improve data consistency and ensure that the trial remains workable for the people taking part as well as the investigators delivering it.
Partner with PHARMExcel for dermatology CRO services
Sponsors choose PHARMExcel because we combine therapeutic understanding, agile clinical operations and a quality-driven approach to trial governance. As a smaller CRO, we offer direct access to senior staff, continuity of team and the flexibility to shape our involvement around the needs of the study, whether that means full service dermatology CRO support or focused assistance with specific parts of the trial.
Our aim is to reduce operational burden, support regulatory readiness and help sponsors deliver high-quality dermatology clinical trials that are feasible in practice as well as robust on paper. For organisations looking for a collaborative and responsive full service CRO partner in dermatology research, PHARMExcel provides practical expertise grounded in real-world clinical trial delivery.
Dermatology CRO FAQs
What dermatology conditions can PHARMExcel support?
PHARMExcel can support clinical trials across a broad range of dermatology indications, including acne, eczema, psoriasis, hidradenitis suppurativa, alopecia, vitiligo and other specialist skin or hair conditions. We can also support dermatology studies linked to oncology pathways where specialist dermatological assessment and follow-up are needed.
Which phases of dermatology trials can PHARMExcel manage?
PHARMExcel supports Phase I-IV clinical trials in dermatology. Our role begins at the clinical trial stage, providing governance, regulatory support and operational oversight once a sponsor is ready to move into human studies.
How does PHARMExcel approach recruitment in dermatology studies?
PHARMExcel does not directly recruit patients. Instead, we provide governance and oversight of site-led recruitment by helping sponsors identify suitable dermatology centres, assess realistic patient pathways and work with investigators who understand the local population and study requirements.
Does PHARMExcel provide pre-clinical dermatology services?
No. PHARMExcel does not provide pre-clinical or laboratory research services. Our focus is on the clinical trial stage, where we support sponsors through governance, regulatory strategy, site coordination and operational delivery.
How does PHARMExcel ensure regulatory compliance in dermatology trials?
We support sponsors with ethics committee and regulatory submissions, safety reporting, monitoring oversight, data management and trial documentation in line with Good Clinical Practice and relevant UK regulatory expectations. Our quality-driven approach helps ensure studies remain compliant, well governed and audit ready.
Why choose PHARMExcel as a dermatology CRO?
Sponsors choose PHARMExcel for our responsive, quality-led approach to clinical trial delivery. As a smaller CRO, we provide direct access to senior staff, continuity of team and practical oversight across the trial lifecycle, helping dermatology studies remain feasible, compliant and patient centred.